The International Consortium of Investigative Journalists

08/28/2026

The Kazakh government is alleging that corruption over contracts awarded by international oil giants resulted in crucial production delays at the Kashagan oil field — costing the country billions.

The allegations, which are at the heart of a confidential arbitration, signal an aggressive new stance by the Central Asian country toward longstanding international partners.

08/27/2026

This month, the IFC's watchdog announced that the board has barred it from processing any new complaints related to microlending and instructed it to suspend all ongoing work on such cases. There are currently 10 such cases in Cambodia and one in Rwanda.

The head of an internal auditor resigned after the board of the World Bank’s private investment arm rejected her office’s findings that the deal violated internal safeguard policies.

08/26/2026

An armed es**rt brought Daniel Kinahan to Dublin’s Special Criminal Court this month. Authorities allege that he oversaw a global narco-trafficking operation tied to a bloody gang war in Ireland that resulted in numerous killings.

Kinahan was taken from Dubai to a Dublin court under armed es**rt and ordered to remain in prison while he awaits trial for his alleged part in running a global drug smuggling empire.

08/25/2026

New safety packaging requirements for cancer drugs sold in India apply not only to those manufactured domestically but also to those imported into the country, such as Keytruda, the focus of ICIJ's recent investigation.

Reporting by ICIJ and The Indian Express illustrated how Indian counterfeiters exploited the high price of the lifesaving cancer drug Keytruda and the desperation of patients seeking it.

08/24/2026

An ICIJ analysis found that at least 11 companies that reportedly had been closely linked to the Syrian President Bashar al-Assad’s regime received roughly $10 million in 2025 after opaque deals and seizures reshaped their ownership.

An ICIJ analysis found that at least 11 firms received roughly $10 million in 2025 after opaque deals and seizures reshaped their ownership.

08/21/2026

Even after authorities seized more than $95 million worth of antiquities from New York’s Metropolitan Museum of Art in recent years, the institution still holds hundreds more pieces linked to alleged looting and trafficking figures, a new analysis by ICIJ has found.

Museum says it wants no stolen artwork and that it has initiated an expedited review of hundreds of works tied to specific dealers.

08/20/2026

A memo from top financial Canadian intelligence officials echos a concern some crypto experts have voiced with urgency: An industry of services converting crypto into large sums of cash has opened a gaping hole in the global bulwark against dirty money.

An internal report obtained says that crypto brokers are moving millions while dodging rules to guard against dirty money.

08/19/2026

The International Finance Corporation’s board rejected its watchdog's findings about violating internal safeguard policies, raising concerns that the World Bank is abandoning its commitment to independent oversight of its private-lending operations.

The head of an internal auditor resigned after the board of the World Bank’s private investment arm rejected her office’s findings that the deal violated internal safeguard policies.

08/18/2026

Leaked records reveal that Italian drug trafficker Giacomo Tamburello and his family, now facing prosecution, accumulated gold bars, luxury real estate and a $89 million stake in a bank with the help of unscrupulous financiers and lawyers.

Italian prosecutors's recent investigation — which has made international headlines because of Tamburellos’ alleged links to one of Italy’s most powerful mafia clans — led to the trio’s arrest in May and the seizure of assets spread across nine jurisdictions.

Read the full story: https://www.icij.org/investigations/pandora-papers/how-offshore-firms-helped-a-mafia-linked-italian-druglord-hide-a-230m-fortune/

08/18/2026

ICIJ’s Austrian partners asked how much all state-run hospitals pay for Keytruda after discounts, if any, and how much they spend on it annually.

None disclosed the actual price. Now, Merck is taking the price transparency battle to court.

The case stems from ICIJ’s Cancer Calculus investigation into the world's best-selling drug’s sky-high price and its global consequences.